Institute for Stem cell Therapy and Exploration of Monogenic diseases
Breaking news
- 5 January 2022 Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
- 24 November 2021 Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders
- 3 November 2021 Human iPSC-derived neurons reveal early developmental alteration of neurite outgrowth in the late-occurring neurodegenerative Wolfram syndrome
I-Stem
Created in 2005 through a collaboration between Inserm – National Institute of Health and Medical Research – and AFM-Telethon – French Association against Myopathies – I-Stem is the largest French laboratory for research and development dedicated to human pluripotent stem cells, of embryonic origin or obtained by reprogramming gene.
I-Stem is part of the Biotherapy Institute for Rare Diseases, which includes so far the three centers of research and development funded directly by the AFM Telethon. (Read more…)
